171 related articles for article (PubMed ID: 27858714)
1. Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.
Carmona-Iragui M; Santos T; Videla S; Fernández S; Benejam B; Videla L; Alcolea D; Blennow K; Blesa R; Lleó A; Fortea J
J Alzheimers Dis; 2017; 55(4):1489-1496. PubMed ID: 27858714
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain.
Alcolea D; Martínez-Lage P; Izagirre A; Clerigué M; Carmona-Iragui M; Alvarez RM; Fortea J; Balasa M; Morenas-Rodríguez E; Lladó A; Grau O; Blennow K; Lleó A; Molinuevo JL
J Alzheimers Dis; 2014; 39(4):719-26. PubMed ID: 24254700
[TBL] [Abstract][Full Text] [Related]
3. [Multicenter study on lumbar puncture indication, clinical practice and feasibility].
Paquet C; Latour F; Saulnier I; Hanon O
Rev Neurol (Paris); 2012 Jan; 168(1):28-32. PubMed ID: 22153704
[TBL] [Abstract][Full Text] [Related]
4. Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.
Duits FH; Martinez-Lage P; Paquet C; Engelborghs S; Lleó A; Hausner L; Molinuevo JL; Stomrud E; Farotti L; Ramakers IHGB; Tsolaki M; Skarsgård C; Åstrand R; Wallin A; Vyhnalek M; Holmber-Clausen M; Forlenza OV; Ghezzi L; Ingelsson M; Hoff EI; Roks G; de Mendonça A; Papma JM; Izagirre A; Taga M; Struyfs H; Alcolea DA; Frölich L; Balasa M; Minthon L; Twisk JWR; Persson S; Zetterberg H; van der Flier WM; Teunissen CE; Scheltens P; Blennow K
Alzheimers Dement; 2016 Feb; 12(2):154-163. PubMed ID: 26368321
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome.
Belbin O; Xiao MF; Xu D; Carmona-Iragui M; Pegueroles J; Benejam B; Videla L; Fernández S; Barroeta I; Nuñez-Llaves R; Montal V; Vilaplana E; Altuna M; Clarimón J; Alcolea D; Blesa R; Lleó A; Worley PF; Fortea J
Mol Neurodegener; 2020 Aug; 15(1):46. PubMed ID: 32807227
[TBL] [Abstract][Full Text] [Related]
6. Safety and acceptability of the research lumbar puncture.
Peskind ER; Riekse R; Quinn JF; Kaye J; Clark CM; Farlow MR; Decarli C; Chabal C; Vavrek D; Raskind MA; Galasko D
Alzheimer Dis Assoc Disord; 2005; 19(4):220-5. PubMed ID: 16327349
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Successful Lumbar Puncture in Alzheimer Research.
Moulder KL; Besser LM; Beekly D; Blennow K; Kukull W; Morris JC
Alzheimer Dis Assoc Disord; 2017; 31(4):287-294. PubMed ID: 28891819
[TBL] [Abstract][Full Text] [Related]
8. Safety of lumbar puncture procedures in patients with Alzheimer's disease.
Peskind E; Nordberg A; Darreh-Shori T; Soininen H
Curr Alzheimer Res; 2009 Jun; 6(3):290-2. PubMed ID: 19519311
[TBL] [Abstract][Full Text] [Related]
9. Repeated lumbar punctures within 3 days may affect CSF biomarker levels.
Olsson M; Ärlig J; Hedner J; Blennow K; Zetterberg H
Fluids Barriers CNS; 2019 Dec; 16(1):37. PubMed ID: 31831030
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).
Prakash N; Caspell-Garcia C; Coffey C; Siderowf A; Tanner CM; Kieburtz K; Mollenhauer B; Galasko D; Merchant K; Foroud T; Chahine LM; Weintraub D; Casaceli C; Dorsey R; Wilson R; Herzog M; Daegele N; Arnedo V; Frasier M; Sherer T; Marek K; Frank S; Jennings D; Simuni T; ; ; ; ;
Parkinsonism Relat Disord; 2019 May; 62():201-209. PubMed ID: 30738748
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated with Lumbar Puncture Participation in Alzheimer's Disease Research.
Blazel MM; Lazar KK; Van Hulle CA; Ma Y; Cole A; Spalitta A; Davenport-Sis N; Bendlin BB; Wahoske M; Illingworth C; Gleason CE; Edwards DF; Blazel H; Asthana S; Johnson SC; Carlsson CM
J Alzheimers Dis; 2020; 77(4):1559-1567. PubMed ID: 32925041
[TBL] [Abstract][Full Text] [Related]
12. The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary.
Hampel H; Elhage A; Shaw LM; Aisen P; Chen C; Lleó A; Iwatsubo T; Iwata A; Yamada M; Ikeuchi T; Jia J; Wang H; Teunissen CE; Peskind E; Blennow K; Cummings J; Vergallo A
Neurodegener Dis Manag; 2022 Oct; 12(5):221-229. PubMed ID: 35866715
[TBL] [Abstract][Full Text] [Related]
13. Safety and Usefulness of Lumbar Puncture for the Diagnosis and Management of Young-Onset Cognitive Disorders.
Soo SA; Zailan FZ; Tan JY; Sandhu GK; Wong BYX; Wang BZ; Ng ASL; Chiew HJ; Ng KP; Kandiah N
J Alzheimers Dis; 2022; 87(1):479-488. PubMed ID: 35275537
[TBL] [Abstract][Full Text] [Related]
14. Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance.
Tautvydaitė D; Kukreja D; Antonietti JP; Henry H; von Gunten A; Popp J
Alzheimers Res Ther; 2017 Feb; 9(1):6. PubMed ID: 28153054
[TBL] [Abstract][Full Text] [Related]
15. Risk-benefit analysis of lumbar puncture to evaluate for nontraumatic subarachnoid hemorrhage in adult ED patients.
Migdal VL; Wu WK; Long D; McNaughton CD; Ward MJ; Self WH
Am J Emerg Med; 2015 Nov; 33(11):1597-601. PubMed ID: 26189054
[TBL] [Abstract][Full Text] [Related]
16. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.
Shaw LM; Arias J; Blennow K; Galasko D; Molinuevo JL; Salloway S; Schindler S; Carrillo MC; Hendrix JA; Ross A; Illes J; Ramus C; Fifer S
Alzheimers Dement; 2018 Nov; 14(11):1505-1521. PubMed ID: 30316776
[TBL] [Abstract][Full Text] [Related]
17. Documentation of cerebrospinal fluid opening pressure and other important aspects of lumbar puncture in acute headache.
Hewett R; Counsell C
Int J Clin Pract; 2010 Jun; 64(7):930-5. PubMed ID: 20584226
[TBL] [Abstract][Full Text] [Related]
18. State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease.
Hampel H; Shaw LM; Aisen P; Chen C; Lleó A; Iwatsubo T; Iwata A; Yamada M; Ikeuchi T; Jia J; Wang H; Teunissen CE; Peskind E; Blennow K; Cummings J; Vergallo A
Alzheimers Dement; 2022 Jan; 18(1):159-177. PubMed ID: 34043269
[TBL] [Abstract][Full Text] [Related]
19. Low risk for subsequent subarachnoid hemorrhage for emergency department patients with headache, bloody cerebrospinal fluid, and negative findings on cerebrovascular imaging.
Thomas LE; Czuczman AD; Boulanger AB; Peak DA; Miller ES; Brown DF; Marill KA
J Neurosurg; 2014 Jul; 121(1):24-31. PubMed ID: 24745707
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
